Search International and National Patent Collections
Some content of this application is unavailable at the moment.
If this situation persists, please contact us atFeedback&Contact
1. (EP3145929) 5-CHLORO-2-DIFLUOROMETHOXYPHENYL PYRAZOLOPYRIMIDINE COMPOUNDS WHICH ARE JAK INHIBITORS

Office : European Patent Office
Application Number: 15726064 Application Date: 22.05.2015
Publication Number: 3145929 Publication Date: 29.03.2017
Publication Kind : A1
Designated States: AL, AT, BA, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, ME, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Prior PCT appl.: Application Number:EP2015061350 ; Publication Number: Click to see the data
IPC:
C07D 487/04
A61K 31/519
A61P 11/06
A61P 29/00
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
D
HETEROCYCLIC COMPOUNDS
487
Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/-C07D477/183
02
in which the condensed system contains two hetero rings
04
Ortho-condensed systems
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
495
having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine
505
Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
519
ortho- or peri-condensed with heterocyclic rings
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
11
Drugs for disorders of the respiratory system
06
Antiasthmatics
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
29
Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (NSAIDs)
CPC:
C07D 471/04
A61K 31/519
A61P 11/06
C07D 403/14
C07D 487/04
C07D 519/00
Applicants: F HOFFMANN-LA ROCHE AG
Inventors: ZAK MARK EDWARD
RAY NICHOLAS CHARLES
GOODACRE SIMON CHARLES
MENDONCA ROHAN
KELLAR TERRY
CHENG YUN-XING
LI WEI
YUEN PO-WAI
Priority Data: 2015077176 22.04.2015 CN
2015061350 22.05.2015 EP
201462002547 23.05.2014 US
201562101234 08.01.2015 US
201562130098 09.03.2015 US
Title: (DE) 5-CHLORO-2-DIFLUORMETHOXYPHENYL-PYRAZOLOPYRIMIDIN-VERBINDUNGEN, DIE JAK-INHIBITOREN SIND
(EN) 5-CHLORO-2-DIFLUOROMETHOXYPHENYL PYRAZOLOPYRIMIDINE COMPOUNDS WHICH ARE JAK INHIBITORS
(FR) COMPOSÉS 5-CHLORO -2-DIFLUOROMÉTHOXYPHÉNYL PYRAZOLOPYRIMIDINE UTILISÉS EN TANT QU'INHIBITEURS DE JAK
Abstract:
(EN) Compounds of Formula (00A) and methods of use as Janus kinase inhibitors are described herein. Claimed uses are the treatment of inflammation and asthma.
(FR) L'invention concerne des composés de formule (00A) et des procédés d'utilisation de ces derniers en tant qu'inhibiteurs de Janus kinases. Les utilisations revendiquées de ces composés sont le traitement de l'inflammation et l'asthme.
Also published as:
CA2948589SG11201609830RIL248661CN106459039AU2015261812US20170145020
JP2017516850KR1020170005870PH1/2016/502099ID2017/12804IN201647039563EA201692338
MYPI 2016002027US20180305355CR20160539WO/2015/177326